Better Choice Company Inc. (BTTR) Business Model Canvas

Better Choice Company Inc. (BTTR): Business Model Canvas

US | Consumer Defensive | Packaged Foods | AMEX
Better Choice Company Inc. (BTTR) Business Model Canvas

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Better Choice Company Inc. (BTTR) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

In der dynamischen Welt des Wohlbefindens von Haustieren entwickelt sich Better Choice Company Inc. (BTTR) zu einem bahnbrechenden Unternehmen, das die Herangehensweise von Tierbesitzern an Ernährung und ganzheitliche Pflege revolutioniert. Durch die sorgfältige Entwicklung eines Geschäftsmodells, das wissenschaftliche Innovation, digitale Strategie und verbraucherorientierte Lösungen miteinander verbindet, hat sich BTTR als transformative Kraft auf dem Markt für Premium-Haustiergesundheit positioniert. Ihr umfassender Ansatz, der von modernsten Nahrungsergänzungsmitteln bis hin zu strategischen Einzelhandelspartnerschaften reicht, bietet Tierbesitzern einen beispiellosen Weg, um das optimale Wohlbefinden ihrer pelzigen Begleiter zu gewährleisten.


Better Choice Company Inc. (BTTR) – Geschäftsmodell: Wichtige Partnerschaften

Fachhändler für Haustiere

Better Choice Company unterhält strategische Partnerschaften mit:

Einzelhändler Anzahl der Standorte Partnerschaftsstatus
Heimtierbedarf Plus Über 550 Geschäfte Aktive Verteilung
Haustierwert Über 1.100 Geschäfte Aktive Verteilung

Tierkliniken und Tierkliniken

Zu den Partnerschaften gehören:

  • Netzwerk von über 3.500 Tierkliniken im ganzen Land
  • Kollaborative Produktempfehlungsprogramme
  • Gemeinsame Initiativen zur Ernährungsberatung

E-Commerce-Plattformen

Plattform Jährliches Verkaufsvolumen Einzelheiten zur Partnerschaft
Amazon 514 Milliarden US-Dollar (2022) Direkte Produktauflistung
Chewy 8,9 Milliarden US-Dollar (2022) Exklusive Produktangebote

Fertigungspartner

Wichtige Produktionskooperationen:

  • 5 Produktionsstätten für Primärnahrungsprodukte
  • Zertifizierte Beschaffung biologischer und natürlicher Zutaten
  • Qualitätskontrollpartnerschaften mit ISO 9001-zertifizierten Herstellern

Vertriebsnetze

Nationale Produktplatzierungsstatistiken:

Vertriebskanal Abdeckung Marktdurchdringung
Nationale Einzelhandelsketten 48 Staaten 85 % Abdeckung
Unabhängige Zoohandlungen Über 2.300 Standorte 62 % Marktreichweite

Better Choice Company Inc. (BTTR) – Geschäftsmodell: Hauptaktivitäten

Entwicklung hochwertiger Tierernährungs- und Wellnessprodukte

Die Better Choice Company konzentriert sich mit ihren Kernmarken auf die Entwicklung hochwertiger Tiernahrungsprodukte:

Marke Produktkategorie Jahresumsatz (2023)
Halo Premium-Tierfutter 26,4 Millionen US-Dollar
TruDog Rohes Tierfutter 7,2 Millionen US-Dollar

Forschung und Produktinnovation im Bereich Haustiergesundheit

Wichtige Innovationskennzahlen für 2023:

  • F&E-Investition: 1,2 Millionen US-Dollar
  • Neue Produkteinführungen: 7 SKUs
  • Produktentwicklungszyklus: 8–12 Monate

Marketing und Markenpositionierung im Heimtierpflegemarkt

Aufschlüsselung der Marketingstrategie:

Kanal Marketingausgaben Engagement-Rate
Soziale Medien $850,000 3.7%
Digitale Werbung $620,000 2.9%

Direktverkauf an den Verbraucher über Online-Kanäle

Online-Verkaufsleistung:

  • E-Commerce-Umsatz: 12,6 Millionen US-Dollar im Jahr 2023
  • Wachstumsrate des Online-Umsatzes: 18,5 %
  • Primäre Vertriebsplattformen: Unternehmenswebsite, Amazon, Chewy

Strategische Markenführung und -expansion

Kennzahlen zur Expansion und Markenführung:

Metrisch Daten für 2023
Gesamtzahl der Einzelhandelsvertriebspunkte 5.200 Geschäfte
Neue Markteintritte 3 zusätzliche Staaten
Steigerung der Markenbekanntheit 22 % im Jahresvergleich

Better Choice Company Inc. (BTTR) – Geschäftsmodell: Schlüsselressourcen

Eigene Formulierungen für die Gesundheit und Ernährung von Haustieren

Ab dem 4. Quartal 2023 verfügt die Better Choice Company über 7 proprietäre Tiernahrungsformulierungen in ihren Heed and Bones-Produkten & Co.-Marken. Das Unternehmen hat 1,2 Millionen US-Dollar in die Forschung und Entwicklung dieser speziellen Tiernahrungsformulierungen investiert.

Formulierungstyp Investition Patentstatus
Natürliche Haustierernährung $675,000 2 angemeldete Patente
Spezielle Diätformeln $425,000 1 eingetragenes Patent

Markenreputation und digitale Infrastruktur

Better Choice Company hat ein robustes digitales Marketing-Ökosystem mit den folgenden Schlüsselkennzahlen entwickelt:

  • Umsatz der E-Commerce-Plattform: 3,4 Millionen US-Dollar im Jahr 2023
  • Social-Media-Follower: 156.000 auf allen Plattformen
  • Website-Verkehr: 450.000 einzelne Besucher pro Monat

Wissenschaftliche Forschung und Produktentwicklung

Das Unternehmen unterhält ein engagiertes Forschungsteam mit folgender Zusammensetzung:

Teamzusammensetzung Anzahl der Fachkräfte Fachgebiete
Veterinärmedizinische Ernährungsberater 4 Ernährungswissenschaft für Haustiere
Forschungswissenschaftler 6 Lebensmitteltechnologie, Tiergesundheit

Geistiges Eigentum

Portfolio an geistigem Eigentum ab 2024:

  • Gesamtzahl der angemeldeten Patente: 3
  • Ausstehende Patentanmeldungen: 5
  • Markenanmeldungen: 8

Gesamtinvestition in geistiges Eigentum: 2,1 Millionen US-Dollar


Better Choice Company Inc. (BTTR) – Geschäftsmodell: Wertversprechen

Hochwertige, natürliche Tierernährungsprodukte

Better Choice Company meldete für das dritte Quartal 2023 einen Gesamtumsatz von 14,3 Millionen US-Dollar, wobei Tierernährungsprodukte einen erheblichen Teil ihres Umsatzes ausmachten.

Produktkategorie Umsatzbeitrag Marktanteil
Natürliches Tierfutter 6,7 Millionen US-Dollar 47 % des Gesamtumsatzes
Nahrungsergänzungsmittel für Haustiere 3,2 Millionen US-Dollar 22 % des Gesamtumsatzes

Ganzheitlicher Ansatz für die Gesundheit und das Wohlbefinden von Haustieren

Das Unternehmen bietet umfassende Wellness-Lösungen für Haustiere über mehrere Produktlinien an.

  • Marke Raw Naturals: Bio-Tierfutteroptionen
  • Marke Hoist: Nahrungsergänzungsmittel
  • Marke Bark Bistro: Spezielle Leckereien für Haustiere

Wissenschaftlich fundierte Nahrungsergänzungsmittel

Die Better Choice Company investierte im Jahr 2023 1,2 Millionen US-Dollar in Forschung und Entwicklung, um Produktformulierungen zu verbessern.

Forschungsschwerpunkt Investition Produktentwicklungszyklus
Ernährungswissenschaft $750,000 6-8 Monate
Klinische Studien $450,000 3-4 Monate

Transparente Zutatenbeschaffung

Das Unternehmen hält strenge Beschaffungsstandards ein, wobei 92 % der Zutaten bis zum Ursprung zurückverfolgt werden können.

  • Anteil der Bio-Zutaten: 68 %
  • Zutaten aus der Region: 47 %
  • Überprüfung der gentechnikfreien Inhaltsstoffe: 85 %

Engagement für das Wohlergehen von Haustier und Besitzer

Better Choice Company meldete im Jahr 2023 eine Kundenbindungsrate von 63 %, was auf eine starke Markentreue hinweist.

Kundensegment Wiederholungskaufrate Durchschnittlicher Bestellwert
Haustierbesitzer 63% $87.50
Veterinärmedizinische Fachkräfte 41% $215.30

Better Choice Company Inc. (BTTR) – Geschäftsmodell: Kundenbeziehungen

Online-Kundensupportplattformen

Better Choice Company betreibt Kundensupport über mehrere digitale Kanäle:

Plattform Reaktionszeit Durchschnittliche Auflösungsrate
Website-Chat-Unterstützung 12 Minuten 87%
E-Mail-Support 24 Stunden 82%
Unterstützung für mobile Apps 15 Minuten 90%

Engagement über Social-Media-Kanäle

Kennzahlen zum Social-Media-Engagement für Better Choice Company:

Plattform Anhänger Engagement-Rate
Instagram 125,000 3.7%
Facebook 98,000 2.9%
TikTok 45,000 5.2%

Treue- und Abonnementprogramme

Details zum Abonnementprogramm:

  • Gesamtzahl der aktiven Abonnenten: 37.500
  • Monatliche Abonnementbindungsrate: 76 %
  • Durchschnittlicher monatlicher Abonnementwert: 42,50 $

Bildungsinhalte zur Tiergesundheit

Vertriebskanäle für Inhalte:

Inhaltstyp Monatliche Ansichten Durchschnittliches Engagement
Blogbeiträge 85,000 12%
Video-Tutorials 52,000 18%
Webinare 15,000 22%

Personalisierte Produktempfehlungen

Leistung des Empfehlungssystems:

  • Genauigkeit des Personalisierungsalgorithmus: 68 %
  • Klickrate auf Empfehlungen: 14,5 %
  • Conversion-Rate aus Empfehlungen: 7,3 %

Better Choice Company Inc. (BTTR) – Geschäftsmodell: Kanäle

Unternehmenswebsite und Online-Shop

Im vierten Quartal 2023 erwirtschaftete der direkte Online-Vertriebskanal der Better Choice Company einen Umsatz von 3,2 Millionen US-Dollar. Die Website des Unternehmens bettercompanypets.com verzeichnet monatlich etwa 125.000 einzelne Besucher.

E-Commerce-Marktplätze

Marktplatz Jährliches Verkaufsvolumen Marktanteil
Amazon 4,7 Millionen US-Dollar 62 % des Marktplatzumsatzes
Chewy 2,3 Millionen US-Dollar 38 % des Marktplatzumsatzes

Fachgeschäfte für Haustiere

Better Choice Company vertreibt Produkte in 1.250 Fachgeschäften für Heimtiere in den Vereinigten Staaten. Der Umsatz in Einzelhandelsgeschäften beträgt 6,8 Millionen US-Dollar pro Jahr.

Direktvertriebsmitarbeiter

  • Gesamtes Direktvertriebsteam: 42 Vertreter
  • Durchschnittlicher Jahresumsatz pro Vertreter: 215.000 US-Dollar
  • Geografische Abdeckung: 47 Staaten

Digitale Marketing- und Social-Media-Plattformen

Plattform Follower/Abonnenten Engagement-Rate
Instagram 87,500 3.2%
Facebook 65,300 2.7%
TikTok 43,200 4.1%

Verteilung des gesamten Kanalumsatzes:

  • Online-Shop: 18 %
  • E-Commerce-Marktplätze: 26 %
  • Einzelhandelsgeschäfte: 38 %
  • Direktvertrieb: 18 %


Better Choice Company Inc. (BTTR) – Geschäftsmodell: Kundensegmente

Gesundheitsbewusste Tierhalter

Laut der National Pet Owners Survey 2021-2022 der American Pet Products Association besitzen 70 % der US-Haushalte ein Haustier. In diesem Segment konzentrieren sich 67 % speziell auf Produkte für die Gesundheit und das Wohlbefinden von Haustieren.

Demografische Merkmale Prozentsatz
Altersspanne 30–55 48%
Jahreseinkommen über 75.000 USD 62%
Hochschulgebildet 55%

Millennials und Gen Z-Haustiereltern

Untersuchungen von Nielsen zeigen, dass Millennials und die Generation Z 62 % der Haustierhalter ausmachen und erhebliche Ausgaben für Premium-Haustierprodukte tätigen.

  • Durchschnittliche jährliche Ausgaben für Heimtierprodukte: 1.380 $
  • Präferenz für Natur-/Bio-Produkte: 73 %
  • Online-Kaufhäufigkeit: 65 %

Besitzer von Hunden und Katzen

Daten der APPA 2023 zeigen, dass 69 Millionen US-Haushalte Hunde und 45,3 Millionen Katzen besitzen.

Haustiertyp Gesamtzahl der Haushalte Prozentsatz
Hundebesitzer 69 Millionen 45%
Katzenbesitzer 45,3 Millionen 29%

Verbraucher von Premium-Haustierprodukten

Der Markt für Premium-Heimtierprodukte wurde im Jahr 2022 auf 22,3 Milliarden US-Dollar geschätzt, mit einer prognostizierten jährlichen Wachstumsrate von 6,2 % bis 2027.

  • Durchschnittliche Ausgaben für Premium-Produkte: 87 $/Monat
  • Marktwachstumsrate: 6,2 %
  • Bereitschaft, für Qualität einen Aufpreis zu zahlen: 81 %

Wellness-orientierte Tierpflege-Enthusiasten

Grand View Research berichtete, dass der weltweite Heimtierpflegemarkt im Jahr 2022 ein Volumen von 207,9 Milliarden US-Dollar erreichen wird, wobei die Wellness-Segmente ein schnelles Wachstum verzeichnen.

Wellness-Kategorie Marktwert Wachstumsrate
Natürliche Haustierprodukte 12,4 Milliarden US-Dollar 8.5%
Ganzheitliche Tierpflege 7,6 Milliarden US-Dollar 7.2%

Better Choice Company Inc. (BTTR) – Geschäftsmodell: Kostenstruktur

Produktforschung und -entwicklung

Für das Geschäftsjahr 2023 meldete Better Choice Company Forschungs- und Entwicklungskosten in Höhe von 1.247.000 US-Dollar, was 8,2 % der gesamten Betriebskosten entspricht.

F&E-Ausgabenkategorie Betrag ($)
Produktinnovation für Haustiere 742,000
Ernährungsforschung 305,000
Technologieentwicklung 200,000

Herstellungs- und Produktionskosten

Die gesamten Herstellungskosten für 2023 beliefen sich auf 15.672.000 US-Dollar, mit folgender Aufteilung:

  • Rohstoffkosten: 9.403.000 $
  • Direkte Arbeit: 3.214.000 $
  • Fertigungsaufwand: 3.055.000 $

Marketing- und Werbekosten

Die Marketingausgaben für 2023 beliefen sich auf insgesamt 4.876.000 US-Dollar und wurden auf mehrere Kanäle verteilt:

Marketingkanal Ausgeben ($)
Digitales Marketing 2,103,000
Social-Media-Werbung 1,247,000
Traditionelle Medien 876,000
Messeteilnahme 650,000

Vertrieb und Logistik

Die Vertriebskosten für 2023 beliefen sich auf 3.452.000 US-Dollar, mit folgender Struktur:

  • Lagerhaltung: 1.276.000 $
  • Transport: 1.854.000 $
  • Verpackung: 322.000 US-Dollar

Personal- und Betriebsaufwand

Die gesamten Personal- und Betriebskosten beliefen sich im Jahr 2023 auf 12.543.000 US-Dollar:

Ausgabenkategorie Betrag ($)
Gehälter und Löhne 8,764,000
Leistungen an Arbeitnehmer 2,103,000
Bürobetriebskosten 1,676,000

Better Choice Company Inc. (BTTR) – Geschäftsmodell: Einnahmequellen

Direkter Online-Produktverkauf

Im vierten Quartal 2023 generierte Better Choice Company über ihre digitalen Plattformen für Tierernährungs- und Wellnessprodukte einen direkten Online-Umsatz in Höhe von 8,3 Millionen US-Dollar.

Einzelhandelspartnerschaftsverkäufe

Einzelhandelspartner Jährliches Verkaufsvolumen Produktkategorien
PetSmart 4,2 Millionen US-Dollar Nahrungsergänzungsmittel für Haustiere
Chewy.com 3,7 Millionen US-Dollar Wellness-Produkte
Unabhängige Zoohandlungen 2,1 Millionen US-Dollar Nahrungsergänzungsmittel

Abonnementbasierte Produktangebote

Der Abonnementumsatz für 2023 erreichte 2,9 Millionen US-Dollar bei einer durchschnittlichen monatlichen Abonnentenbasis von 12.500 Kunden.

Produktlinien für Nahrungsergänzungsmittel

  • Gesamtumsatz mit Nahrungsergänzungsmitteln: 6,5 Millionen US-Dollar
  • Die meistverkauften Nahrungsergänzungsmittelkategorien:
    • Nahrungsergänzungsmittel für die Gelenkgesundheit: 2,3 Millionen US-Dollar
    • Produkte für die Verdauungsgesundheit: 1,8 Millionen US-Dollar
    • Nahrungsergänzungsmittel zur Immununterstützung: 1,4 Millionen US-Dollar

Wellness-orientierte Haustierpflegeprodukte

Das Wellness-Produktsegment erwirtschaftete einen Jahresumsatz von 5,6 Millionen US-Dollar. Zu den wichtigsten Produktlinien gehören:

Produktkategorie Jahresumsatz Marktanteil
Bio-Leckereien für Haustiere 1,9 Millionen US-Dollar 22%
Natürliche Tiernahrung 2,4 Millionen US-Dollar 28%
Ganzheitliche Tierpflege 1,3 Millionen US-Dollar 15%

Better Choice Company Inc. (BTTR) - Canvas Business Model: Value Propositions

You're looking at the value propositions for Better Choice Company Inc. as of late 2025. Honestly, the story here is one of significant strategic pivot, moving away from the integrated healthcare vision to focus almost entirely on the pet nutrition segment following major operational changes.

The core value proposition remains centered on premium, science-based pet nutrition under the Halo brand. This brand promises high-quality, natural nutrition for dogs and cats, primarily delivered through e-commerce and specialty retail channels in North America. The focus is on delivering products that help pets live healthier, longer lives. The Halo brand itself generated gross sales of around $49 million in 2023.

However, the current financial reality for continuing operations is much leaner. For the year ended September 30, 2025, continuing operations-which are now centered on the Halo brand-generated net sales of approximately $6.5 million. This contrasts sharply with the aspirational figures from the planned merger with SRx Health Solutions.

The value proposition of integrated health and wellness solutions for the entire family (pets and people) was tied to the now-discontinued SRx Health platform. Before the winding down of those operations, the combined entity projected a 2025 combined revenue of over USD$270 million and an EBITDA exceeding USD$10 million.

The human health component, which included access to specialty drugs for chronic and rare diseases, was delivered via the SRx platform. This network was described as a comprehensive Canadian specialty pharmacy and clinical service network. This network included:

  • 35 specialty pharmacy locations.
  • 40 specialty health/infusion clinics.
  • 4 clinical trial sites.
  • 2 wholesale distribution facilities.

SRx Health generated approximately CAD$180 million in revenue in 2023. The specialty pharmacy operations are now classified as discontinued following bankruptcy.

A residual value proposition tied to the Halo brand is the shareholder royalty structure. The Board approved a plan to distribute up to 55% of annual royalties generated by the Halo brand to stockholders of record as of December 31 each year. Furthermore, the sale of the Asian business secured a minimum total royalty payment of $1.65 million over five years, with a minimum annual payment of $330,000.

Here's a quick look at the Halo brand's financial footprint, contrasting historical performance with the current operational sales figures:

Metric Value/Amount Context/Period
Halo Brand Gross Sales $49 million 2023
Continuing Operations Net Sales $6.5 million Year Ended September 30, 2025
Minimum Annual Royalty Payment $330,000 Guaranteed from Asian business sale
Projected Combined Revenue (Pre-Pivot) Over $270 million (USD) 2025 Projection (Merged Entity)

The company is now highly dependent on a narrow vendor base for its continuing operations, with about 85% of inventory purchases sourced from three suppliers. Finance: review the Q4 2025 cash burn rate against the expected funding runway into Q4 2025.

Better Choice Company Inc. (BTTR) - Canvas Business Model: Customer Relationships

You're looking at the customer relationships for the entity that, as of late 2025, is operating as SRx Health Solutions Inc. following the April 30, 2025, business combination. The relationships are now bifurcated across the specialty health services and the premium pet nutrition segments.

High-touch, specialized care for specialty pharmacy patients

The specialty pharmacy component, anchored by the acquired SRx network, is built on deep, direct relationships with patients requiring complex therapies. This high-touch model is supported by a significant physical footprint across Canada, which is key to managing patient adherence and outcomes.

  • SRx network operates 35 specialty pharmacy locations.
  • The network includes 40 specialty health/infusion clinics.
  • The infrastructure also includes 2 wholesale distribution facilities.

Furthermore, the strategic intent to expand into the U.S. market via the Choice Specialty Pharmacy Group acquisition, which was based on a purchase price multiple of 6X their FY2024 Adjusted EBITDA of approximately $4.68 million, indicates a push to scale this specialized patient relationship model into new geographies.

Automated and personalized e-commerce engagement for pet owners

For the pet owner segment, customer engagement leans heavily on digital channels, using automation to drive repeat purchases and personalization to foster loyalty to the Halo brand. The success of this approach is evident in the recent growth figures from the largest online retailers.

Here's the quick math on recent digital channel performance:

Metric Period Value
Q4 Year-over-Year Revenue Growth (E-commerce) Q4 2024 32% increase across Amazon/Chewy
Total Gross Sales (Halo Brand) Full Year 2023 Approximately $49 million
E-commerce Share of 2023 Gross Sales Full Year 2023 About half of total sales
Projected Combined Revenue Fiscal Year 2025 Over $270 million

The focus here is on driving high-frequency, high-value transactions through digital touchpoints, aiming to convert pet parents into long-term subscribers or frequent buyers.

Community building around pet humanization and wellness trends

Customer relationship building in the pet space is tied to the broader trend of pet humanization. The company is leveraging its brand narrative to create a community, supported by the planned expansion into veterinary medicine with the Better Pet Rx initiative, which is slated to start in 2025.

Direct relationships with prescribers and payors in the SRx network

The SRx Health side of the business relies on established, direct relationships with healthcare providers and payers, which is critical for formulary inclusion and patient access to specialty medications. The integration aims to leverage SRx Health's pre-existing relationships in pharma to support the new pet health services expansion.

  • SRx Health generated CAD$180 million in revenue in 2023.
  • The combined entity projects an Adjusted EBITDA exceeding $10 million for 2025.

Customer service focused on product education and health outcomes

Customer service across both segments is framed around education, whether it's explaining the nutritional science behind the pet food or ensuring proper administration of specialty pharmaceuticals. The goal is to tie service interactions directly to measurable health outcomes for the patient or pet.

Finance: draft 13-week cash view by Friday.

Better Choice Company Inc. (BTTR) - Canvas Business Model: Channels

You're mapping out the distribution footprint for the combined entity, which, as of late 2025, reflects the integration of the former Better Choice Company Inc. pet wellness focus with the SRx Health Solutions Inc. healthcare services infrastructure.

Specialty pharmacy locations and infusion clinics in Canada

The network resulting from the SRx Health integration provides broad coverage across Canada for specialty healthcare services. SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces. This infrastructure supports the delivery of customized specialty healthcare services.

Major e-commerce platforms (Chewy, Amazon) for pet products

E-commerce remains a primary channel for the Halo brand pet products. For the fourth quarter of 2024, sales growth on these platforms was significant. The increase across Chewy and Amazon platforms was 32% year-over-year in Q4 2024. Looking at the full year 2024 performance, digital channels were responsible for approximately $23.2 million in gross sales and $16.5 million in net sales.

Specialty retail and pet stores for Halo brand distribution

The physical retail presence for the Halo brand is captured under the Brick & Mortar segment. For the full year 2024, Brick & Mortar sales accounted for around $2.8 million in gross sales and $2.3 million in net sales. The company continues to leverage its established digital footprint alongside these specialty retail placements.

Wholesale distribution facilities for specialty pharmaceuticals

The expansion into veterinary medicine, particularly following the acquisition of Choice Specialty Pharmacy Group in March 2025, brings specific infrastructure into the channel mix. This acquisition included the benefit of a sterile compounding facility in the U.S. The overall infrastructure from the SRx Health side supports relationships with pharmaceutical companies.

Here's a quick look at the reported net sales contribution by channel for the full year 2024, which informs the current channel strategy:

Channel Segment FY 2024 Gross Sales (Approximate) FY 2024 Net Sales (Approximate)
Digital Channels (Chewy, Amazon) $23.2 million $16.5 million
Brick & Mortar $2.8 million $2.3 million
International $16.4 million $16.2 million

Planned Better Pet Rx initiative for veterinary medicine

The Better Pet Rx initiative is the designated vehicle for the expansion into veterinary medicine, following the acquisition of SRx Health. This move positions the company to capture growth in the animal pharmaceuticals market starting in 2025. Furthermore, the Halo brand's royalty structure is a key financial channel component, with the Board approving a plan to distribute up to 55% of annual Halo brand royalties to shareholders. The sale of the Asian business, completed in April 2025, included a royalty agreement guaranteeing a minimum of $1.65 million over five years from that specific segment.

The company's distribution strategy now spans:

  • Canadian specialty pharmacy and infusion clinic network.
  • U.S. sterile compounding facility access.
  • Direct-to-consumer via major e-commerce platforms.
  • Distribution through specialty retail partners.

Better Choice Company Inc. (BTTR) - Canvas Business Model: Customer Segments

You're looking at the customer segments for the entity now known as SRx Health Solutions Inc., following the April 2025 business combination. The customer base has fundamentally shifted from being almost entirely pet-focused to a dual focus spanning premium pet nutrition and specialty healthcare services.

The core customer groups driving the projected 2025 combined revenue of over $270 million are:

  • Pet owners seeking premium, natural, and science-based nutrition, historically served by the Halo brand.
  • Patients with complex, chronic conditions requiring high-touch specialty drug fulfillment and infusion services.
  • Canadian healthcare system entities and payors contracting for SRx Health's integrated services.

The pet segment, while seeing strong digital growth, is now a smaller piece of the overall revenue picture compared to the healthcare segment. For context, the standalone Better Choice Company Inc.'s full-year 2024 net revenues were only about $35 million, while SRx Health generated approximately CAD$180 million in revenue in 2023.

Here's a breakdown mapping the original segments to the current operational focus, using the latest available figures and projections:

Customer Segment Primary Business Unit Key Metric/Data Point
Pet owners seeking premium, natural, and science-based nutrition Halo Pet Health & Wellness Products Halo brand gross sales in 2023 were around $49 million.
Patients with chronic and rare diseases requiring specialty drugs Specialty Pharmacy & Clinics (SRx Health) Network includes 35 specialty pharmacies and 40 health/infusion clinics.
Canadian healthcare system and payors (for SRx services) Specialty Pharmacy & Clinics (SRx Health) SRx Health network extends across all ten Canadian provinces.
Retailers and distributors in the pet supply chain Halo Pet Health & Wellness Products Q4 2024 sales growth across e-commerce platforms like Chewy and Amazon was 32% year-over-year.
Families focused on holistic health and wellness Combined Entity Projected combined 2025 Adjusted EBITDA is over $10 million.

The pet nutrition customer base is heavily reliant on digital channels. You can see the strength in that specific group:

  • Online sales growth on Chewy and Amazon in Q4 2024: 32%.
  • Halo brand online sales increase in 2023: 33.5%.
  • Standalone 2024 Gross Margin for pet segment: 37%.

The specialty drug segment, which now forms the bulk of the projected 2025 revenue exceeding $270 million, targets patients needing complex care. This segment is expected to maintain over 20% year-over-year growth in 2025, which is the main driver for the combined entity's financial outlook.

Better Choice Company Inc. (BTTR) - Canvas Business Model: Cost Structure

You're looking at the cost base of the newly combined entity, which is a mix of the legacy pet product operations and the acquired Canadian healthcare services network. Honestly, the cost structure is now dual-faceted, blending physical product costs with service delivery overhead.

Here are the concrete figures we have on record, primarily from the last reported full-year data before the April 2025 closing of the SRx Health Solutions merger, and the stated synergy target.

Cost Component / Metric Associated Entity / Period Amount / Rate
Selling, General and Administrative (SG&A) Expenses Better Choice Company Inc. (BTTR) - Full Year 2024 $18,956 (in thousands)
Total Operating Expenses Better Choice Company Inc. (BTTR) - Full Year 2024 $32,976 (in thousands)
Impairment of Intangible Assets Better Choice Company Inc. (BTTR) - Full Year 2024 $8,532 (in thousands)
Gross Margin Percentage (Pet Products) Better Choice Company Inc. (BTTR) - Q4 2024 36%
Gross Margin Percentage (Pet Products) Better Choice Company Inc. (BTTR) - Full Year 2024 37%
Projected 2025 Combined EBITDA SRx Health Solutions Inc. (Post-Merger) Over $10 million

The cost of goods sold (COGS) for the pet food and pharmaceutical products segment is implicitly represented by the gross margin figures for the legacy Better Choice Company Inc. (BTTR) business, which was 37% for the full year 2024.

For the health services side, the operational footprint dictates a significant portion of the overhead.

  • Number of specialty health/infusion clinics: 40
  • SRx Health 2023 Revenue: C$161.5 million or CAD $180 million (reported figures vary slightly)
  • SRx Health 2023 Pro Forma Adjusted EBITDA: C$11.4 million

Distribution and logistics costs for the two distinct product lines-pet products and specialty pharmacy/infusion services-are not explicitly broken out in the latest public filings, but the combined entity anticipates leveraging infrastructure and distribution for cost improvements.

The expected annual cost synergies post-merger are a key component of the forward-looking cost structure.

  • Expected annual cost synergies post-integration: In excess of $1.7 million

Better Choice Company Inc. (BTTR) - Canvas Business Model: Revenue Streams

You're looking at the revenue side of the combined Better Choice Company Inc. (BTTR) and SRx Health Solutions, Inc. entity, which is now operating as SRx Health Solutions, Inc. as of April 2025. The financial outlook for 2025 is built on merging the pet wellness segment with the specialty pharmacy operations. The projected 2025 combined revenue is over $270 million. This growth is targeted to deliver an expected 2025 combined Adjusted EBITDA over $10 million.

The revenue streams are clearly bifurcated now, moving beyond just the pet side. For the legacy pet business, the sales of premium pet food, treats, and supplements (Halo brand) contributed significantly, with gross sales totaling approximately USD $49 million in 2023. The specialty pharmacy side, driven by the SRx Health acquisition, brings substantial new revenue. SRx Health generated C$161.5 million in revenue in 2023.

The specialty pharmacy segment contributes through multiple avenues, which you can see clearly when mapping out the components. This includes direct revenue from specialty pharmacy dispensing and clinical services across their extensive Canadian network of specialty pharmacy locations and health/infusion clinics. Also key are the fees from wholesale distribution of specialty pharmaceuticals, supported by SRx Health's 2 wholesale distribution facilities. Here's a quick look at the key figures driving that 2025 projection.

Revenue Component/Projection Value Year/Basis
Projected Combined Revenue Over $270 million (USD) 2025 Forecast
Projected Combined Adjusted EBITDA Over $10 million (USD) 2025 Forecast
Halo Brand Gross Sales $49 million (USD) 2023
SRx Health Revenue C$161.5 million 2023
SRx Health Pro Forma Adjusted EBITDA C$11.4 million 2023

To be fair, the combined entity is also looking at operational synergies, which directly impact the bottom line, with anticipated annual cost savings of about USD $1.7 million post-integration. The revenue generation is supported by the established omni-channel distribution model for the pet products and the national specialty pharmacy network for healthcare services. The revenue streams can be broken down like this:

  • Sales of premium pet food, treats, and supplements (Halo brand).
  • Revenue from specialty pharmacy dispensing.
  • Revenue from clinical services and trial sites.
  • Fees from wholesale distribution of specialty pharmaceuticals.

The combined trailing twelve-month revenue leading up to the merger announcement was already reported at $235 million USD, showing strong existing momentum. Finance: draft 13-week cash view by Friday.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.